{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T03:54:30Z","timestamp":1792641270571,"version":"4.5.0"},"reference-count":181,"publisher":"Frontiers Media SA","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2014.00257","type":"journal-article","created":{"date-parts":[[2014,6,3]],"date-time":"2014-06-03T12:33:34Z","timestamp":1401798814000},"source":"Crossref","is-referenced-by-count":38,"title":["Immune Defects in the Risk of Infection and Response to Vaccination in Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma"],"prefix":"10.3389","volume":"5","author":[{"given":"Sarah M.","family":"Tete","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Bijl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surinder S.","family":"Sahota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolaas A.","family":"Bos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2014,6,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1086\/313792","article-title":"Epidemiology and unique aspects of aging and infectious diseases","volume":"30","author":"Yoshikawa","year":"2000","journal-title":"Clin Infect Dis"},{"key":"B2","doi-asserted-by":"publisher","first-page":"5412","DOI":"10.1182\/blood-2008-12-194241","article-title":"Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study","volume":"113","author":"Landgren","year":"2009","journal-title":"Blood"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1056\/NEJMoa054494","article-title":"Prevalence of monoclonal gammopathy of undetermined significance","volume":"354","author":"Kyle","year":"2006","journal-title":"N Engl J Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1038\/leu.2008.203","article-title":"Pathogenesis and progression of monoclonal gammopathy of undetermined significance","volume":"22","author":"Blade","year":"2008","journal-title":"Leukemia"},{"key":"B5","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s00277-011-1293-1","article-title":"Prevalence and progression of monoclonal gammopathy of undetermined significance and light-chain MGUS in Germany","volume":"91","author":"Eisele","year":"2012","journal-title":"Ann Hematol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1016\/S0140-6736(10)60482-5","article-title":"Prevalence and risk of progression of light-chain monoclonal gammopathy of undetermined significance: a retrospective population-based cohort study","volume":"375","author":"Dispenzieri","year":"2010","journal-title":"Lancet"},{"key":"B7","doi-asserted-by":"publisher","first-page":"5418","DOI":"10.1182\/blood-2008-12-195008","article-title":"A monoclonal gammopathy precedes multiple myeloma in most patients","volume":"113","author":"Weiss","year":"2009","journal-title":"Blood"},{"key":"B8","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1182\/blood-2005-03-1038","article-title":"Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance","volume":"106","author":"Rajkumar","year":"2005","journal-title":"Blood"},{"key":"B9","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1056\/NEJMoa0806122","article-title":"B-cell clones as early markers for chronic lymphocytic leukemia","volume":"360","author":"Landgren","year":"2009","journal-title":"Mayo Clin Proc"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1038\/leu.2011.70","article-title":"Evaluating the clonal hierarchy in light-chain multiple myeloma: implications against the myeloma stem cell hypothesis","volume":"25","author":"Pfeifer","year":"2011","journal-title":"Leukemia"},{"key":"B11","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1046\/j.1365-2141.2003.04355.x","article-title":"Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group","volume":"121","year":"2003","journal-title":"Br J Haematol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1111\/j.1365-2141.1992.tb08245.x","article-title":"Malignant transformation and life expectancy in monoclonal gammopathy of undetermined significance","volume":"81","author":"Blade","year":"1992","journal-title":"Br J Haematol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1084\/jem.20021650","article-title":"A reversible defect in natural killer T cell function characterizes the progression of premalignant to malignant multiple myeloma","volume":"197","author":"Dhodapkar","year":"2003","journal-title":"J Exp Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1084\/jem.20031030","article-title":"Vigorous premalignancy-specific effector T cell response in the bone marrow of patients with monoclonal gammopathy","volume":"198","author":"Dhodapkar","year":"2003","journal-title":"J Exp Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1084\/jem.20062387","article-title":"Frequent and specific immunity to the embryonal stem cell-associated antigen SOX2 in patients with monoclonal gammopathy","volume":"204","author":"Spisek","year":"2007","journal-title":"J Exp Med"},{"key":"B16","first-page":"392","article-title":"Immunophenotypic approach to the identification and characterization of clonal plasma cells from patients with monoclonal gammopathies","volume":"18","author":"Perez-Andres","year":"2004","journal-title":"J Biol Regul Homeost Agents"},{"key":"B17","doi-asserted-by":"publisher","first-page":"2582","DOI":"10.1056\/NEJMoa070389","article-title":"Clinical course and prognosis of smoldering (asymptomatic) multiple myeloma","volume":"356","author":"Kyle","year":"2007","journal-title":"N Engl J Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"2516","DOI":"10.1182\/blood-2007-10-116129","article-title":"Improved survival in multiple myeloma and the impact of novel therapies","volume":"111","author":"Kumar","year":"2008","journal-title":"Blood"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1038\/leu.2008.402","article-title":"Improved survival of patients with multiple myeloma after the introduction of novel agents and the applicability of the International Staging System (ISS): an analysis of the Greek Myeloma Study Group (GMSG)","volume":"23","author":"Kastritis","year":"2009","journal-title":"Leukemia"},{"key":"B20","doi-asserted-by":"publisher","first-page":"854","DOI":"10.3324\/haematol.2011.054015","article-title":"Monoclonal gammopathy of undetermined significance and risk of infections: a population-based study","volume":"97","author":"Kristinsson","year":"2012","journal-title":"Haematologica"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.3324\/haematol.2009.010066","article-title":"Patterns of survival and causes of death following a diagnosis of monoclonal gammopathy of undetermined significance: a population-based study","volume":"94","author":"Kristinsson","year":"2009","journal-title":"Haematologica"},{"key":"B22","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1128\/CVI.00021-11","article-title":"Comparative study of immune status to infectious agents in elderly patients with multiple myeloma, Waldenstrom\u00e2\u20ac\u2122s macroglobulinemia, and monoclonal gammopathy of undetermined significance","volume":"18","author":"Karlsson","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1111\/j.1365-2141.1983.tb02021.x","article-title":"Abnormal monoclonal antibody-defined helper\/suppressor T-cell subpopulations in multiple myeloma: relationship to treatment and clinical stage","volume":"53","author":"Mills","year":"1983","journal-title":"Br J Haematol"},{"key":"B24","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1097\/00007611-197906000-00032","article-title":"Hemophilus influenzae septicemia and polyarthritis in multiple myeloma","volume":"72","author":"Saba","year":"1979","journal-title":"South Med J"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1080\/10428190500472503","article-title":"Immune parameters in multiple myeloma patients: influence of treatment and correlation with opportunistic infections","volume":"47","author":"Schutt","year":"2006","journal-title":"Leuk Lymphoma"},{"key":"B26","doi-asserted-by":"publisher","first-page":"9219","DOI":"10.1200\/JCO.2005.03.2086","article-title":"Early mortality after diagnosis of multiple myeloma: analysis of patients entered onto the United Kingdom Medical Research Council trials between 1980 and 2002 \u00e2\u20ac\u201c Medical Research Council Adult Leukaemia Working Party","volume":"23","author":"Augustson","year":"2005","journal-title":"J Clin Oncol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"47","DOI":"10.7326\/0003-4819-96-1-47","article-title":"Biphasic pattern of bacterial infection in multiple myeloma","volume":"96","author":"Savage","year":"1982","journal-title":"Ann Intern Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1159\/000225611","article-title":"Changing patterns of infections in patients with multiple myeloma","volume":"39","author":"Shaikh","year":"1982","journal-title":"Oncology"},{"key":"B29","first-page":"517","article-title":"Perspectives in multiple myeloma: survival, prognostic factors and disease complications in a single centre between 1975 and 1988","volume":"79","author":"Rayner","year":"1991","journal-title":"Q J Med"},{"key":"B30","first-page":"282","article-title":"Immunosuppression and infection in multiple myeloma","volume":"13","author":"Jacobson","year":"1986","journal-title":"Semin Oncol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.blre.2008.07.003","article-title":"Lenalidomide in combination with dexamethasone for the treatment of relapsed or refractory multiple myeloma","volume":"23","author":"Palumbo","year":"2009","journal-title":"Blood Rev"},{"key":"B32","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1002\/ajh.22237","article-title":"Multiple myeloma: 2012 update on diagnosis, risk-stratification, and management","volume":"87","author":"Rajkumar","year":"2012","journal-title":"Am J Hematol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/S0140-6736(06)68338-4","article-title":"Oral melphalan and prednisone chemotherapy plus thalidomide compared with melphalan and prednisone alone in elderly patients with multiple myeloma: randomised controlled trial","volume":"367","author":"Palumbo","year":"2006","journal-title":"Lancet"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1086\/605664","article-title":"Infections in patients with multiple myeloma in the era of high-dose therapy and novel agents","volume":"49","author":"Nucci","year":"2009","journal-title":"Clin Infect Dis"},{"key":"B35","doi-asserted-by":"publisher","first-page":"4784","DOI":"10.1200\/JCO.2007.14.9641","article-title":"Analysis of herpes zoster events among bortezomib-treated patients in the phase III APEX study","volume":"26","author":"Chanan-Khan","year":"2008","journal-title":"J Clin Oncol"},{"key":"B36","first-page":"1022","article-title":"Risk factors for the development of bacterial infections in multiple myeloma treated with two different vincristine-adriamycin-dexamethasone schedules","volume":"88","author":"Cesana","year":"2003","journal-title":"Haematologica"},{"key":"B37","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1111\/j.1365-2141.2006.06405.x","article-title":"A randomised comparison of melphalan with prednisone or dexamethasone as induction therapy and dexamethasone or observation as maintenance therapy in multiple myeloma: NCIC CTG MY.7","volume":"136","author":"Shustik","year":"2007","journal-title":"Br J Haematol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S1470-2045(09)70284-0","article-title":"Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial","volume":"11","author":"Rajkumar","year":"2010","journal-title":"Lancet Oncol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1038\/sj.leu.2404226","article-title":"Pathogen-associated molecular patterns are growth and survival factors for human myeloma cells through Toll-like receptors","volume":"20","author":"Jego","year":"2006","journal-title":"Leukemia"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1038\/sj.leu.2404225","article-title":"Toll-like receptors mediate proliferation and survival of multiple myeloma cells","volume":"20","author":"Bohnhorst","year":"2006","journal-title":"Leukemia"},{"key":"B41","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1146\/annurev-immunol-030409-101216","article-title":"Early events in B cell activation","volume":"28","author":"Harwood","year":"2010","journal-title":"Annu Rev Immunol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.coi.2010.10.007","article-title":"Regulation of T follicular helper cell formation and function by antigen presenting cells","volume":"23","author":"Deenick","year":"2011","journal-title":"Curr Opin Immunol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"2741","DOI":"10.4049\/jimmunol.180.5.2741","article-title":"Mechanisms for decreased function of B cells in aged mice and humans","volume":"180","author":"Frasca","year":"2008","journal-title":"J Immunol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/0531-5565(94)90036-1","article-title":"Age-related changes in immune parameters in a very old population of Swedish people: a longitudinal study","volume":"29","author":"Wikby","year":"1994","journal-title":"Exp Gerontol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S0047-6374(00)00210-4","article-title":"Age-related change in peripheral blood T-lymphocyte subpopulations and cytomegalovirus infection in the very old: the Swedish longitudinal OCTO immune study","volume":"121","author":"Olsson","year":"2001","journal-title":"Mech Ageing Dev"},{"key":"B46","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/nri2508","article-title":"B-cell responses to vaccination at the extremes of age","volume":"9","author":"Siegrist","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"3262","DOI":"10.4049\/jimmunol.175.5.3262","article-title":"Regulation of aged humoral immune defense against pneumococcal bacteria by IgM memory B cell","volume":"175","author":"Shi","year":"2005","journal-title":"J Immunol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.mad.2009.08.003","article-title":"A double-negative (IgD- CD27) B cell population is increased in the peripheral blood of elderly people","volume":"130","author":"Colonna-Romano","year":"2009","journal-title":"Mech Ageing Dev"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.3324\/haematol.2009.018689","article-title":"Circulating human B and plasma cells. Age-associated changes in counts and detailed characterization of circulating normal CD138- and CD138 plasma cells","volume":"95","author":"Caraux","year":"2010","journal-title":"Haematologica"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1182\/blood-2011-01-331462","article-title":"Toll-like receptor 7 (TLR7)-driven accumulation of a novel CD11c B-cell population is important for the development of autoimmunity","volume":"118","author":"Rubtsov","year":"2011","journal-title":"Blood"},{"key":"B51","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1084\/jem.20022020","article-title":"Human immunoglobulin M memory B cells controlling Streptococcus pneumoniae infections are generated in the spleen","volume":"197","author":"Kruetzmann","year":"2003","journal-title":"J Exp Med"},{"key":"B52","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1007\/s10875-010-9501-7","article-title":"Aging affects human B cell responses","volume":"31","author":"Frasca","year":"2011","journal-title":"J Clin Immunol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1111\/j.1474-9726.2011.00732.x","article-title":"Vaccination-induced changes in human B-cell repertoire and pneumococcal IgM and IgA antibody at different ages","volume":"10","author":"Ademokun","year":"2011","journal-title":"Aging Cell"},{"key":"B54","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/j.1474-9726.2008.00443.x","article-title":"B-cell diversity decreases in old age and is correlated with poor health status","volume":"8","author":"Gibson","year":"2009","journal-title":"Aging Cell"},{"key":"B55","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/S0531-5565(01)00210-8","article-title":"Role of humoral and cell-mediated immunity in protection from influenza disease after immunization of healthy elderly","volume":"37","author":"Murasko","year":"2002","journal-title":"Exp Gerontol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/S0264-410X(98)00117-0","article-title":"Immune response to influenza vaccination in a large healthy elderly population","volume":"17","author":"Bernstein","year":"1999","journal-title":"Vaccine"},{"key":"B57","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/0264-410X(89)90150-3","article-title":"Antibody induction by influenza vaccines in the elderly: a review of the literature","volume":"7","author":"Beyer","year":"1989","journal-title":"Vaccine"},{"key":"B58","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/0264-410X(89)90198-9","article-title":"Immune response to trivalent inactivated influenza vaccine in young and elderly subjects","volume":"7","author":"Iorio","year":"1989","journal-title":"Vaccine"},{"key":"B59","doi-asserted-by":"publisher","first-page":"CD001269","DOI":"10.1002\/14651858.CD001269.pub3","article-title":"Vaccines for preventing influenza in healthy adults","volume":"2","author":"Demicheli","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1001\/jama.272.21.1661","article-title":"The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial","volume":"272","author":"Govaert","year":"1994","journal-title":"JAMA"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1016\/j.vaccine.2005.08.105","article-title":"Antibody response to influenza vaccination in the elderly: a quantitative review","volume":"24","author":"Goodwin","year":"2006","journal-title":"Vaccine"},{"key":"B62","doi-asserted-by":"publisher","first-page":"3109","DOI":"10.1172\/JCI57834","article-title":"Limited efficacy of inactivated influenza vaccine in elderly individuals is associated with decreased production of vaccine-specific antibodies","volume":"121","author":"Sasaki","year":"2011","journal-title":"J Clin Invest"},{"issue":"Suppl 1","key":"B63","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1093\/infdis\/165-Supplement_1-S49","article-title":"Thymus-independent and thymus-dependent responses to polysaccharide antigens","volume":"165","author":"Stein","year":"1992","journal-title":"J Infect Dis"},{"key":"B64","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1542\/peds.74.5.857","article-title":"Serum antibodies after vaccination with Haemophilus influenzae type b capsular polysaccharide and responses to reimmunization: no evidence of immunologic tolerance or memory","volume":"24","author":"K\u00c3\u00a4yhty","year":"1984","journal-title":"Pedriatics"},{"key":"B65","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1128\/IAI.40.1.245-256.1983","article-title":"Further studies on the immunogenicity of Haemophilus influenzae type b and pneumococcal type 6A polysaccharide-protein conjugates","volume":"40","author":"Chu","year":"1983","journal-title":"Infect Immun"},{"key":"B66","doi-asserted-by":"publisher","first-page":"S46","DOI":"10.1016\/0264-410X(93)90160-Y","article-title":"Effect of immunity to the carrier protein on antibody responses to Haemophilus influenzae type b conjugate vaccines","volume":"11","author":"Granoff","year":"1993","journal-title":"Vaccine"},{"key":"B67","doi-asserted-by":"crossref","first-page":"5979","DOI":"10.1128\/IAI.67.11.5979-5984.1999","article-title":"Determination of antibody responses of elderly adults to all 23 capsular polysaccharides after pneumococcal vaccination","volume":"67","author":"Rubins","year":"1999","journal-title":"Infect Immun"},{"key":"B68","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1086\/515644","article-title":"Magnitude, duration, quality, and function of pneumococcal vaccine responses in elderly adults","volume":"178","author":"Rubins","year":"1998","journal-title":"J Infect Dis"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1016\/S0140-6736(00)04237-9","article-title":"Effects of a large-scale intervention with influenza and 23-valent pneumococcal vaccines in adults aged 65 years or older: a prospective study","volume":"357","author":"Christenson","year":"2001","journal-title":"Lancet"},{"key":"B70","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1086\/507340","article-title":"Protective effects of the 23-valent pneumococcal polysaccharide vaccine in the elderly population: the EVAN-65 study","volume":"43","author":"Vila-C\u00c3\u00b3rcoles","year":"2006","journal-title":"Clin Infect Dis"},{"key":"B71","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1016\/S0140-6736(05)67339-4","article-title":"Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review","volume":"366","author":"Jefferson","year":"2005","journal-title":"Lancet"},{"key":"B72","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1086\/431524","article-title":"Antibody responses to nasopharyngeal carriage of Streptococcus pneumoniae in adults: a longitudinal household study","volume":"192","author":"Goldblatt","year":"2005","journal-title":"J Infect Dis"},{"key":"B73","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1128\/CVI.00110-08","article-title":"Effects of ageing and gender on naturally acquired antibodies to pneumococcal capsular polysaccharides and virulence-associated proteins","volume":"15","author":"Simell","year":"2008","journal-title":"Clin Vaccine Immunol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0002-9343(97)00149-6","article-title":"Clinical efficacy of pneumococcal vaccine in the elderly: a randomized, single-blind population-based trial","volume":"103","author":"Koivula","year":"1997","journal-title":"Am J Med"},{"key":"B75","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1016\/S0264-410X(99)00069-9","article-title":"Incremental effectiveness of pneumococcal vaccine on simultaneously administered influenza vaccine in preventing pneumonia and pneumococcal pneumonia among persons aged 65 years or older","volume":"17","author":"Honkanen","year":"1999","journal-title":"Vaccine"},{"key":"B76","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/j.1365-2567.2004.01971.x","article-title":"Haemophilus influenzae type b conjugate vaccines","volume":"113","author":"Kelly","year":"2004","journal-title":"Immunology"},{"key":"B77","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1006\/biol.1994.1062","article-title":"Difficulties in establishing a serological correlate of protection after immunization with Haemophilus influenzae conjugate vaccines","volume":"22","author":"K\u00c3\u00a4yhty","year":"1994","journal-title":"Biologicals"},{"key":"B78","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1128\/IAI.66.4.1752-1754.1998","article-title":"Aging and the immune response to the Haemophilus influenzae type b capsular polysaccharide: retention of the dominant idiotype and antibody function in the elderly","volume":"66","author":"Lucas","year":"1998","journal-title":"Infect Immun"},{"key":"B79","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S0264-410X(96)00164-8","article-title":"Phase I study of the immunogenicity and safety of conjugated Hemophilus influenzae type b vaccines in the elderly","volume":"15","author":"Kantor","year":"1997","journal-title":"Vaccine"},{"key":"B80","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1182\/blood-2003-09-3277","article-title":"Monoclonal CD5 and CD5-B-lymphocyte expansions are frequent in the peripheral blood of the elderly","volume":"103","author":"Ghia","year":"2004","journal-title":"Blood"},{"key":"B81","doi-asserted-by":"publisher","first-page":"3095","DOI":"10.1182\/blood-2001-12-0297","article-title":"Flow cytometric disease monitoring in multiple myeloma: the relationship between normal and neoplastic plasma cells predicts outcome after transplantation","volume":"100","author":"Rawstron","year":"2002","journal-title":"Blood"},{"key":"B82","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/0047-6374(84)90167-2","article-title":"Autoantibodies in highly aged humans","volume":"26","author":"Hijmans","year":"1984","journal-title":"Mech Ageing Dev"},{"key":"B83","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1084\/jem.20050341","article-title":"T cell aging naive but not young","volume":"201","author":"Nikolich-\u00c5\u00bdugich","year":"2005","journal-title":"J Exp Med"},{"key":"B84","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1093\/gerona\/glr237","article-title":"T-cell biology in aging, with a focus on lung disease","volume":"67","author":"Lee","year":"2012","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"B85","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/978-1-4419-6451-9_15","article-title":"Memory T-cell homeostasis and senescence during aging","volume-title":"Memory T Cells Anonymous","author":"Henson","year":"2010"},{"key":"B86","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/j.1600-0609.1998.tb01075.x","article-title":"The risk of bacteremia in patients with monoclonal gammopathy of undetermined significance","volume":"61","author":"Gregersen","year":"1998","journal-title":"Eur J Haematol"},{"key":"B87","first-page":"1172","article-title":"The impact of M-component type and immunoglobulin concentration on the risk of malignant transformation in patients with monoclonal gammopathy of undetermined significance","volume":"86","author":"Gregersen","year":"2001","journal-title":"Haematologica"},{"key":"B88","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1182\/blood.V87.3.912.bloodjournal873912","article-title":"Role of different hematologic variables in defining the risk of malignant transformation in monoclonal gammopathy","volume":"87","author":"Baldini","year":"1996","journal-title":"Blood"},{"key":"B89","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1200\/JCO.20.6.1625","article-title":"Prognostic factors for malignant transformation in monoclonal gammopathy of undetermined significance and smoldering multiple myeloma","volume":"20","author":"Cesana","year":"2002","journal-title":"J Clin Oncol"},{"key":"B90","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/BF02785839","article-title":"Mechanisms of polyclonal hypogammaglobulinaemia in multiple myeloma (MM)","volume":"16","author":"Kyrtsonis","year":"1999","journal-title":"Med Oncol"},{"key":"B91","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1111\/j.1365-2141.2009.07929.x","article-title":"Risk of progression in smouldering myeloma and monoclonal gammopathies of unknown significance: comparative analysis of the evolution of monoclonal component and multiparameter flow cytometry of bone marrow plasma cells","volume":"148","author":"Perez-Persona","year":"2010","journal-title":"Br J Haematol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1038\/leu.2012.189","article-title":"Suppression of uninvolved immunoglobulins defined by heavy\/light chain pair suppression is a risk factor for progression of MGUS","volume":"27","author":"Katzmann","year":"2013","journal-title":"Leukemia"},{"key":"B93","doi-asserted-by":"publisher","first-page":"3","DOI":"10.7243\/2052-434X-1-3","article-title":"IgG antibody and TH1 immune responses to influenza vaccination negatively correlate with M-protein burden in monoclonal gammopathy of undetermined significance","volume":"1","author":"Tete","year":"2013","journal-title":"Hematol Leuk"},{"key":"B94","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.1080\/10428190802464729","article-title":"Enumeration of blood dendritic cells in patients with multiple myeloma at presentation and through therapy","volume":"49","author":"Harrison","year":"2008","journal-title":"Leuk Lymphoma"},{"key":"B95","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3324\/haematol.2012.067272","article-title":"Analysis of the immune system of multiple myeloma patients achieving long-term disease control by multidimensional flow cytometry","volume":"98","author":"Pessoa de Magalh\u00c3\u00a3es","year":"2013","journal-title":"Haematologica"},{"key":"B96","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1472-6890-8-13","article-title":"Immunophenotypic studies of monoclonal gammopathy of undetermined significance","volume":"8","author":"Olteanu","year":"2008","journal-title":"BMC Clin Pathol"},{"key":"B97","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1038\/sj.leu.2404815","article-title":"A single-tube six-colour flow cytometry screening assay for the detection of minimal residual disease in myeloma","volume":"21","author":"de Tute","year":"2007","journal-title":"Leukemia"},{"key":"B98","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1309\/AJCPKKNPMLWX9ZXB","article-title":"Single tube, six-color flow cytometric analysis is a sensitive and cost-effective technique for assaying clonal plasma cells","volume":"133","author":"Marsee","year":"2010","journal-title":"Am J Clin Pathol"},{"key":"B99","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1309\/VWXARAAG9DAPQ31Y","article-title":"Four-color flow cytometric analysis of myeloma plasma cells","volume":"126","author":"Kobayashi","year":"2006","journal-title":"Am J Clin Pathol"},{"key":"B100","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1038\/leu.2010.320","article-title":"Competition between clonal plasma cells and normal cells for potentially overlapping bone marrow niches is associated with a progressively altered cellular distribution in MGUS vs. myeloma","volume":"25","author":"Paiva","year":"2011","journal-title":"Leukemia"},{"key":"B101","doi-asserted-by":"publisher","first-page":"526","DOI":"10.4149\/neo_2009_06_526","article-title":"Phenotype of plasma cells in multiple myeloma and monoclonal gammopathy of undetermined significance","volume":"56","author":"Kovarova","year":"2009","journal-title":"Neoplasma"},{"key":"B102","doi-asserted-by":"publisher","first-page":"5668","DOI":"10.1200\/JCO.2005.03.159","article-title":"Prognostic value of circulating plasma cells in monoclonal gammopathy of undetermined significance","volume":"23","author":"Kumar","year":"2005","journal-title":"J Clin Oncol"},{"key":"B103","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1182\/blood.V88.1.289.289","article-title":"Clonal circulating cells are common in plasma cell proliferative disorders: a comparison of monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and active myeloma","volume":"88","author":"Billadeau","year":"1996","journal-title":"Blood"},{"key":"B104","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1046\/j.1365-2141.1997.72653.x","article-title":"Circulating plasma cells in multiple myeloma: characterization and correlation with disease stage","volume":"97","author":"Rawstron","year":"1997","journal-title":"Br J Haematol"},{"key":"B105","first-page":"1655","article-title":"Immunophenotypic characterization of plasma cells from monoclonal gammopathy of undetermined significance patients. Implications for the differential diagnosis between MGUS and multiple myeloma","volume":"152","author":"Ocqueteau","year":"1998","journal-title":"Am J Pathol"},{"key":"B106","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.1182\/blood-2005-05-1858","article-title":"Circulating plasma cells detected by flow cytometry as a predictor of survival in 302 patients with newly diagnosed multiple myeloma","volume":"106","author":"Nowakowski","year":"2005","journal-title":"Blood"},{"key":"B107","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1182\/blood.V88.5.1780.1780","article-title":"Peripheral blood monoclonal plasma cells as a predictor of survival in patients with multiple myeloma","volume":"88","author":"Witzig","year":"1996","journal-title":"Blood"},{"key":"B108","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1056\/NEJMoa01133202","article-title":"A long-term study of prognosis in monoclonal gammopathy of undetermined significance","volume":"346","author":"Kyle","year":"2002","journal-title":"N Engl J Med"},{"key":"B109","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1002\/hon.704","article-title":"T cells in myeloma","volume":"21","author":"Raitakari","year":"2003","journal-title":"Hematol Oncol"},{"key":"B110","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1080\/10245330310001652437","article-title":"Th1\/Th2 cells in patients with multiple myeloma","volume":"9","author":"Murakami","year":"2004","journal-title":"Hematology"},{"key":"B111","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.4049\/jimmunol.169.5.2498","article-title":"Cytokine coexpression during human Th1\/Th2 cell differentiation: direct evidence for coordinated expression of Th2 cytokines","volume":"169","author":"Cousins","year":"2002","journal-title":"J Immunol"},{"key":"B112","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1101\/gad.14.14.1693","article-title":"Lineage commitment in the immune system: the T helper lymphocyte grows up","volume":"14","author":"Glimcher","year":"2000","journal-title":"Genes Dev"},{"key":"B113","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s002620050616","article-title":"Intracellular cytokine profile of T cells from children with acute lymphoblastic leukemia","volume":"49","author":"Zhang","year":"2000","journal-title":"Cancer Immunol Immunother"},{"key":"B114","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1007\/s00262-001-0232-8","article-title":"T-helper (Th)1\/Th2 imbalance in patients with previously untreated B-cell diffuse large cell lymphoma","volume":"50","author":"Mori","year":"2001","journal-title":"Cancer Immunol Immunother"},{"key":"B115","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1046\/j.1365-2249.2001.01582.x","article-title":"Deregulated cytokine network and defective Th1 immune response in multiple myeloma","volume":"125","author":"Frassanito","year":"2001","journal-title":"Clin Exp Immunol"},{"key":"B116","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1046\/j.1365-2141.2003.04375.x","article-title":"Viral antigen-specific CD8+ T-cell responses are impaired in multiple myeloma","volume":"121","author":"Maecker","year":"2003","journal-title":"Br J Haematol"},{"key":"B117","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1038\/nm0804-801","article-title":"Regulatory T cells and mechanisms of immune system control","volume":"10","author":"O\u00e2\u20ac\u2122Garra","year":"2004","journal-title":"Nat Med"},{"key":"B118","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/ar1226","article-title":"Regulating the immune system: the induction of regulatory T cells in the periphery","volume":"6","author":"Buckner","year":"2004","journal-title":"Arthritis Res Ther"},{"key":"B119","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.autrev.2005.04.005","article-title":"CD4 regulatory T cells: mechanisms of induction and effector function","volume":"4","author":"Bacchetta","year":"2005","journal-title":"Autoimmun Rev"},{"key":"B120","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.coi.2008.02.003","article-title":"Emerging concepts in CD8 T regulatory cells","volume":"20","author":"Niederkorn","year":"2008","journal-title":"Curr Opin Immunol"},{"key":"B121","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1385\/IR:35:1:163","article-title":"Double-negative regulatory T cells","volume":"35","author":"Thomson","year":"2006","journal-title":"Immunol Res"},{"key":"B122","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1111\/j.1365-2222.2006.02606.x","article-title":"Regulation of the T cell response","volume":"36","author":"Romagnani","year":"2006","journal-title":"Clin Exp Allergy"},{"key":"B123","doi-asserted-by":"publisher","first-page":"5986","DOI":"10.4049\/jimmunol.172.10.5986","article-title":"IL-10-secreting regulatory T cells do not express Foxp3 but have comparable regulatory function to naturally occurring CD4 CD25 regulatory T cells","volume":"172","author":"Vieira","year":"2004","journal-title":"J Immunol"},{"key":"B124","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1182\/blood-2005-08-3101","article-title":"Dysfunctional T regulatory cells in multiple myeloma","volume":"107","author":"Prabhala","year":"2006","journal-title":"Blood"},{"key":"B125","doi-asserted-by":"publisher","first-page":"3940","DOI":"10.1182\/blood-2005-09-3671","article-title":"In vivo peripheral expansion of naive CD4+CD25high FoxP3+ regulatory T cells in patients with multiple myeloma","volume":"107","author":"Beyer","year":"2006","journal-title":"Blood"},{"key":"B126","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1111\/j.1365-2141.2008.07530.x","article-title":"CD4(+)CD25(+)FoxP3(+) regulatory T cells are increased whilst CD3(+)CD4(\u00e2\u02c6\u2019)CD8(\u00e2\u02c6\u2019)alphabetaTCR(+) double negative T cells are decreased in the peripheral blood of patients with multiple myeloma which correlates with disease burden","volume":"144","author":"Feyler","year":"2009","journal-title":"Br J Haematol"},{"key":"B127","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1038\/bjc.2011.575","article-title":"The frequency of T regulatory cells modulates the survival of multiple myeloma patients: detailed characterisation of immune status in multiple myeloma","volume":"106","author":"Giannopoulos","year":"2012","journal-title":"Br J Cancer"},{"key":"B128","first-page":"51","article-title":"Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in self-tolerance and autoimmune disease","volume":"305","author":"Sakaguchi","year":"2006","journal-title":"Curr Top Microbiol Immunol"},{"key":"B129","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1182\/blood.V100.1.230","article-title":"Dendritic cells are functionally defective in multiple myeloma: the role of interleukin-6","volume":"100","author":"Ratta","year":"2002","journal-title":"Blood"},{"key":"B130","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/j.1365-2249.2006.03037.x","article-title":"Impaired functionality and phenotypic profile of dendritic cells from patients with multiple myeloma","volume":"144","author":"Brimnes","year":"2006","journal-title":"Clin Exp Immunol"},{"key":"B131","doi-asserted-by":"publisher","first-page":"2992","DOI":"10.1182\/blood.V98.10.2992","article-title":"Dendritic cells from patients with myeloma are numerically normal but functionally defective as they fail to up-regulate CD80 (B7-1) expression after huCD40LT stimulation because of inhibition by transforming growth factor-beta1 and interleukin-10","volume":"98","author":"Brown","year":"2001","journal-title":"Blood"},{"key":"B132","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1111\/j.1365-2141.2004.04984.x","article-title":"Either interleukin-12 or interferon-gamma can correct the dendritic cell defect induced by transforming growth factor beta in patients with myeloma","volume":"125","author":"Brown","year":"2004","journal-title":"Br J Haematol"},{"key":"B133","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1038\/sj.leu.2404734","article-title":"Bortezomib significantly impairs the immunostimulatory capacity of human myeloid blood dendritic cells","volume":"21","author":"Straube","year":"2007","journal-title":"Leukemia"},{"key":"B134","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1002\/eji.200535298","article-title":"Proteasome inhibitor-induced apoptosis in human monocyte-derived dendritic cells","volume":"36","author":"Nencioni","year":"2006","journal-title":"Eur J Immunol"},{"key":"B135","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.ccr.2009.08.019","article-title":"Functional interaction of plasmacytoid dendritic cells with multiple myeloma cells: a therapeutic target","volume":"16","author":"Chauhan","year":"2009","journal-title":"Cancer Cell"},{"key":"B136","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/978-1-4614-5260-7_6","article-title":"Dendritic cells and peptide-based vaccine in multiple myeloma","volume-title":"Advances in Biology and Therapy of Multiple Myeloma","author":"Bae","year":"2013"},{"key":"B137","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/S0268-960X(96)90040-5","article-title":"B7-mediated costimulation and the immune response","volume":"10","author":"Schultze","year":"1996","journal-title":"Blood Rev"},{"key":"B138","doi-asserted-by":"publisher","first-page":"2688","DOI":"10.4049\/jimmunol.178.5.2688","article-title":"NKp46 and NKG2D recognition of infected dendritic cells is necessary for NK cell activation in the human response to influenza infection","volume":"178","author":"Draghi","year":"2007","journal-title":"J Immunol"},{"key":"B139","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1172\/JCI117399","article-title":"Influenza virus-infected dendritic cells stimulate strong proliferative and cytolytic responses from human CD8 T cells","volume":"94","author":"Bhardwaj","year":"1994","journal-title":"J Clin Invest"},{"key":"B140","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1046\/j.1365-2141.1996.4651006.x","article-title":"Analysis of natural killer-associated antigens in peripheral blood and bone marrow of multiple myeloma patients and prognostic implications","volume":"93","author":"Garcia-Sanz","year":"1996","journal-title":"Br J Haematol"},{"key":"B141","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/j.1600-0609.1990.tb00443.x","article-title":"Natural killer cell activity in monoclonal gammopathies: relation to disease activity","volume":"45","author":"Osterborg","year":"1990","journal-title":"Eur J Haematol"},{"key":"B142","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1002\/ajh.2830390203","article-title":"Increased expression of natural-killer-associated and activation antigens in multiple myeloma","volume":"39","author":"Gonzalez","year":"1992","journal-title":"Am J Hematol"},{"key":"B143","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/S0145-2126(07)70390-9","article-title":"Clinical stage-depending decrease of NK cell activity in multiple myeloma patients","volume":"24","author":"Jurisic","year":"2007","journal-title":"Med Oncol"},{"key":"B144","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1111\/imm.12082","article-title":"Differential expression of natural killer cell activating receptors in blood vs. bone marrow in patients with monoclonal gammopathy","volume":"139","author":"Costello","year":"2013","journal-title":"Immunology"},{"key":"B145","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1182\/blood-2004-04-1422","article-title":"HLA class I, NKG2D, and natural cytotoxicity receptors regulate multiple myeloma cell recognition by natural killer cells","volume":"105","author":"Carbone","year":"2005","journal-title":"Blood"},{"key":"B146","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1073\/pnas.0711293105","article-title":"MHC class I chain-related protein A antibodies and shedding are associated with the progression of multiple myeloma","volume":"105","author":"Jinushi","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B147","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/s00262-009-0807-3","article-title":"Reduced immune effector cell NKG2D expression and increased levels of soluble NKG2D ligands in multiple myeloma may not be causally linked","volume":"59","author":"von Lilienfeld-Toal","year":"2010","journal-title":"Cancer Immunol Immunother"},{"key":"B148","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1182\/blood.V98.1.210","article-title":"Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myeloma","volume":"98","author":"Davies","year":"2001","journal-title":"Blood"},{"key":"B149","doi-asserted-by":"publisher","first-page":"168","DOI":"10.3109\/10428194.2013.794270","article-title":"Modulation of NK cell effector functions through lenalidomide\/dasatinib and their combined effects against multiple myeloma cells","volume":"55","author":"Jungkunz-Stier","year":"2014","journal-title":"Leuk Lymphoma"},{"key":"B150","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1111\/j.1365-2141.2007.06705.x","article-title":"Immunodeficiency and immunotherapy in multiple myeloma","volume":"138","author":"Pratt","year":"2007","journal-title":"Br J Haematol"},{"key":"B151","doi-asserted-by":"publisher","first-page":"553","DOI":"10.4049\/jimmunol.167.1.553","article-title":"Suppression of IL-2-induced T cell proliferation and phosphorylation of STAT3 and STAT5 by tumor-derived TGF beta is reversed by IL-15","volume":"167","author":"Campbell","year":"2001","journal-title":"J Immunol"},{"key":"B152","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1182\/blood.V95.8.2630","article-title":"Vascular endothelial growth factor and interleukin-6 in paracrine tumor-stromal cell interactions in multiple myeloma","volume":"95","author":"Dankbar","year":"2000","journal-title":"Blood"},{"key":"B153","doi-asserted-by":"publisher","first-page":"4784","DOI":"10.1182\/blood-2004-11-4201","article-title":"Cyclooxygenase-2 (COX-2) is frequently expressed in multiple myeloma and is an independent predictor of poor outcome","volume":"105","author":"Ladetto","year":"2005","journal-title":"Blood"},{"key":"B154","doi-asserted-by":"publisher","first-page":"518","DOI":"10.7326\/0003-4819-123-7-199510010-00008","article-title":"The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature","volume":"123","author":"Gross","year":"1995","journal-title":"Ann Intern Med"},{"key":"B155","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/oxfordjournals.bmb.a071545","article-title":"Determinants of immunity to influenza infection in man","volume":"35","author":"Potter","year":"1979","journal-title":"Br Med Bull"},{"key":"B156","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1054\/bjoc.1999.1088","article-title":"Immunogenicity of vaccination against influenza, Streptococcus pneumoniae and Haemophilus influenzae type B in patients with multiple myeloma","volume":"82","author":"Robertson","year":"2000","journal-title":"Br J Cancer"},{"key":"B157","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1111\/j.1365-2141.2005.05582.x","article-title":"Vaccination of patients with haematological malignancies with one or two doses of influenza vaccine: a randomised study","volume":"130","author":"Ljungman","year":"2005","journal-title":"Br J Haematol"},{"key":"B158","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/00002030-199404000-00008","article-title":"Antibody response to influenza, tetanus and pneumococcal vaccines in HIV-seropositive individuals in relation to the number of CD4+ lymphocytes","volume":"8","author":"Kroon","year":"1994","journal-title":"AIDS"},{"key":"B159","first-page":"1","article-title":"Antibody response to a two-dose regimen of influenza vaccine in allogenic T cell-depleted and autologous BMT recipients","volume":"11","author":"Engelhard","year":"1993","journal-title":"Bone Marrow Transplant"},{"key":"B160","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1034\/j.1600-0609.2003.00028.x","article-title":"Influenza vaccine in chronic lymphoproliferative disorders and multiple myeloma","volume":"70","author":"Rapezzi","year":"2003","journal-title":"Eur J Haematol"},{"key":"B161","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S0022-1759(80)80004-4","article-title":"A radioimmunoassay for immunologic phenomena in pneumococcal disease and for the antibody response to pneumococcal vaccines. I. Method for the radioimmunoassay of anticapsular antibodies and comparison with other techniques","volume":"33","author":"Schiffman","year":"1980","journal-title":"J Immunol Methods"},{"issue":"Suppl","key":"B162","doi-asserted-by":"publisher","first-page":"S184","DOI":"10.1093\/clinids\/3.Supplement_1.S184","article-title":"Assessment of the antibody response to pneumococcal vaccine in high-risk populations","volume":"3","author":"Landesman","year":"1981","journal-title":"Rev Infect Dis"},{"key":"B163","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1093\/infdis\/143.4.590","article-title":"Antibody response to pneumococcal vaccine in patients with multiple myeloma","volume":"143","author":"Schmid","year":"1981","journal-title":"J Infect Dis"},{"key":"B164","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1111\/j.1600-0609.1983.tb01500.x","article-title":"Antibody response to pneumococcal vaccination in patients with myelomatosis","volume":"30","author":"Birgens","year":"1983","journal-title":"Scand J Haematol"},{"key":"B165","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/0002-9343(80)90014-5","article-title":"Pneumococcal vaccination: the response of patients with multiple myeloma","volume":"69","author":"Lazarus","year":"1980","journal-title":"Am J Med"},{"key":"B166","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1136\/jcp.48.3.260","article-title":"Immunological factors and risk of infection in plateau phase myeloma","volume":"48","author":"Hargreaves","year":"1995","journal-title":"J Clin Pathol"},{"key":"B167","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1128\/CVI.05675-11","article-title":"Risk of invasive Haemophilus influenzae type b (Hib) disease in adults with secondary immunodeficiency in the post-Hib vaccine era","volume":"19","author":"Nix","year":"2012","journal-title":"Clin Vaccine Immunol"},{"key":"B168","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1182\/blood.V76.8.1647.1647","article-title":"B-cell differentiation following autologous, conventional, or T-cell depleted bone marrow transplantation: a recapitulation of normal B-cell ontogeny","volume":"76","author":"Small","year":"1990","journal-title":"Blood"},{"key":"B169","first-page":"395","article-title":"Reconstitution of B cell immunity following bone marrow transplantation","volume":"9","author":"Storek","year":"1992","journal-title":"Bone Marrow Transplant"},{"key":"B170","first-page":"2","article-title":"Immunologic reconstitution after human marrow grafting","volume":"21","author":"Witherspoon","year":"1984","journal-title":"Semin Hematol"},{"key":"B171","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1182\/blood.V60.3.578.578","article-title":"Analysis of T lymphocytes after bone marrow transplantation using monoclonal antibodies","volume":"60","author":"Fox","year":"1982","journal-title":"Blood"},{"key":"B172","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1084\/jem.161.6.1483","article-title":"Phenotype of recovering lymphoid cell populations after marrow transplantation","volume":"161","author":"Ault","year":"1985","journal-title":"J Exp Med"},{"key":"B173","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/sj.bmt.1703239","article-title":"Antibody responses to vaccinations given within the first two years after transplant are similar between autologous peripheral blood stem cell and bone marrow transplant recipients","volume":"28","author":"Gandhi","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"B174","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1097\/TP.0b013e3181772a75","article-title":"Evaluation of immune responses to seasonal influenza vaccination in healthy volunteers and in patients after stem cell transplantation","volume":"86","author":"Avetisyan","year":"2008","journal-title":"Transplantation"},{"key":"B175","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/bmt.2008.264","article-title":"Influenza vaccination in hematopoietic SCT recipients","volume":"42","author":"Ljungman","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"B176","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/sj.bmt.1701641","article-title":"Immunization of transplant recipients","volume":"23","author":"Ljungman","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"B177","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1111\/j.1600-0463.2012.02922.x","article-title":"Serologic response to a 23-valent pneumococcal vaccine administered prior to autologous stem cell transplantation in patients with multiple myeloma","volume":"120","author":"Hinge","year":"2012","journal-title":"APMIS"},{"key":"B178","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1111\/j.1365-2249.1992.tb06480.x","article-title":"Class- and subclass-specific pneumococcal antibody levels and response to immunization after bone marrow transplantation","volume":"88","author":"Lortan","year":"1992","journal-title":"Clin Exp Immunol"},{"key":"B179","first-page":"961","article-title":"A comparison of early and late vaccination with Haemophilus influenzae type b conjugate and pneumococcal polysaccharide vaccines after allogenic BMT","volume":"18","author":"Parkkali","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"B180","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1038\/nm1310","article-title":"Restoration of immunity in lymphopenic individuals with cancer by vaccination and adoptive T-cell transfer","volume":"11","author":"Rapoport","year":"2005","journal-title":"Nat Med"},{"key":"B181","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1182\/blood-2010-07-296822","article-title":"Transfer of influenza vaccine-primed costimulated autologous T cells after stem cell transplantation for multiple myeloma leads to reconstitution of influenza immunity: results of a randomized clinical trial","volume":"117","author":"Stadtmauer","year":"2011","journal-title":"Blood"}],"container-title":["Frontiers in Immunology"],"original-title":[],"deposited":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T19:55:57Z","timestamp":1649188557000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2014.00257\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,3]]},"references-count":181,"URL":"https:\/\/doi.org\/10.3389\/fimmu.2014.00257","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,3]]}}}